These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Rapid agonist-induced phosphorylation of the human CRF receptor, type 1: a potential mechanism for homologous desensitization. Hauger RL; Smith RD; Braun S; Dautzenberg FM; Catt KJ Biochem Biophys Res Commun; 2000 Feb; 268(2):572-6. PubMed ID: 10679245 [TBL] [Abstract][Full Text] [Related]
48. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. Martínez V; Wang L; Rivier JE; Vale W; Taché Y J Pharmacol Exp Ther; 2002 May; 301(2):611-7. PubMed ID: 11961064 [TBL] [Abstract][Full Text] [Related]
50. Peritoneal fluid levels of immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein (CRF-BP) in healthy and endometriosic women. Florio P; Busacca M; Vignali M; Viganò P; Woods RJ; Lowry PJ; Genazzani AR; Luisi S; Santuz M; Petraglia F J Endocrinol Invest; 1998 Jan; 21(1):37-42. PubMed ID: 9633021 [TBL] [Abstract][Full Text] [Related]
51. Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes. Maciejewski D; Crowe PD; De Souza EB; Behan DP J Pharmacol Exp Ther; 1996 Aug; 278(2):455-61. PubMed ID: 8768691 [TBL] [Abstract][Full Text] [Related]
52. Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Heinrichs SC; Lapsansky J; Behan DP; Chan RK; Sawchenko PE; Lorang M; Ling N; Vale WW; De Souza EB Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15475-80. PubMed ID: 8986836 [TBL] [Abstract][Full Text] [Related]
53. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Gulyas J; Rivier C; Perrin M; Koerber SC; Sutton S; Corrigan A; Lahrichi SL; Craig AG; Vale W; Rivier J Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10575-9. PubMed ID: 7479843 [TBL] [Abstract][Full Text] [Related]
54. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. Heinrichs SC; Vale EA; Lapsansky J; Behan DP; McClure LV; Ling N; De Souza EB; Schulteis G Peptides; 1997; 18(5):711-6. PubMed ID: 9213365 [TBL] [Abstract][Full Text] [Related]
55. Circulating human corticotropin-releasing factor-binding protein levels following cortisol infusions. Kasckow JW; Lupien SJ; Behan DP; Welge J; Hauger RJ Life Sci; 2001 Jun; 69(2):133-42. PubMed ID: 11441903 [TBL] [Abstract][Full Text] [Related]
56. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628 [TBL] [Abstract][Full Text] [Related]
57. Corticotropin-releasing factor-binding protein (CRF-BP) inhibits CRF- and urotensin-I-mediated activation of CRF receptor-1 and -2 in common carp. Manuel R; Metz JR; Flik G; Vale WW; Huising MO Gen Comp Endocrinol; 2014 Jun; 202():69-75. PubMed ID: 24769042 [TBL] [Abstract][Full Text] [Related]
58. The effect of magnesium sulfate on the placental corticotropin-releasing factor (CRF) and CRF binding protein mRNA expression in perfused human placental cotyledon. Kropach N; Holtzman D; Vitner D; Bar J; Chen A; Kovo M J Matern Fetal Neonatal Med; 2016; 29(3):376-9. PubMed ID: 25655525 [TBL] [Abstract][Full Text] [Related]